TINOS THERAPEUTICS
Live / Applied — New application — not yet assigned to an examiner (as of 29 Jan 2026)
What this means for you
Not registered yet, but its 29 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99622513
- Mark type
- Stylized text
- Filed
- 29 Jan 2026
- Attorney of record
- Nicole Kinsley
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); pharmaceuticals, namely, viral vector therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)
- Class 040 — Treatment of materials: Custom manufacturing of pharmaceuticals
- Class 042 — Scientific and technological services: Pharmaceutical products development; Pharmaceutical research and development
- Class 044 — Medical, beauty and agricultural services: Genetic analysis for medical purposes
Owner
- Tinos Therapeutics, Inc., Barrington, RI, US
Prosecution history
- 31 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 29 Jan 2026 — NEW APPLICATION ENTERED